Canada · Delayed Price · Currency is CAD Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of CAD 425.32 million. The enterprise value is 1.07 billion.
| Market Cap | 425.32M |
| Enterprise Value | 1.07B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 369.84 million shares outstanding. The number of shares has increased by 3.13% in one year.
| Current Share Class | 353.07M |
| Shares Outstanding | 369.84M |
| Shares Change (YoY) | +3.13% |
| Shares Change (QoQ) | +1.20% |
| Owned by Insiders (%) | 2.79% |
| Owned by Institutions (%) | 17.99% |
| Float | 344.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 1.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.28 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.20 |
| EV / EBITDA | 5.10 |
| EV / EBIT | 10.27 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 2.40.
| Current Ratio | 2.51 |
| Quick Ratio | 0.72 |
| Debt / Equity | 2.40 |
| Debt / EBITDA | 3.90 |
| Debt / FCF | -3,622.11 |
| Interest Coverage | 1.25 |
Financial Efficiency
Return on equity (ROE) is -45.77% and return on invested capital (ROIC) is 9.47%.
| Return on Equity (ROE) | -45.77% |
| Return on Assets (ROA) | 3.64% |
| Return on Invested Capital (ROIC) | 9.47% |
| Return on Capital Employed (ROCE) | 6.79% |
| Weighted Average Cost of Capital (WACC) | 9.96% |
| Revenue Per Employee | 308,733 |
| Profits Per Employee | -64,521 |
| Employee Count | 2,900 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 3.28 |
Taxes
In the past 12 months, Cresco Labs has paid 62.15 million in taxes.
| Income Tax | 62.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +76.92% in the last 52 weeks. The beta is 1.71, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.71 |
| 52-Week Price Change | +76.92% |
| 50-Day Moving Average | 1.30 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 43.13 |
| Average Volume (20 Days) | 154,875 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of CAD 895.33 million and -187.11 million in losses. Loss per share was -0.52.
| Revenue | 895.33M |
| Gross Profit | 448.61M |
| Operating Income | 104.27M |
| Pretax Income | -135.81M |
| Net Income | -187.11M |
| EBITDA | 171.30M |
| EBIT | 104.27M |
| Loss Per Share | -0.52 |
Balance Sheet
The company has 45.15 million in cash and 819.06 million in debt, with a net cash position of -773.92 million or -2.09 per share.
| Cash & Cash Equivalents | 45.15M |
| Total Debt | 819.06M |
| Net Cash | -773.92M |
| Net Cash Per Share | -2.09 |
| Equity (Book Value) | 340.88M |
| Book Value Per Share | 1.26 |
| Working Capital | 207.28M |
Cash Flow
In the last 12 months, operating cash flow was 51.36 million and capital expenditures -51.59 million, giving a free cash flow of -226,129.
| Operating Cash Flow | 51.36M |
| Capital Expenditures | -51.59M |
| Depreciation & Amortization | 67.91M |
| Net Borrowing | -85.19M |
| Free Cash Flow | -226,129 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 50.11%, with operating and profit margins of 11.65% and -20.90%.
| Gross Margin | 50.11% |
| Operating Margin | 11.65% |
| Pretax Margin | -15.17% |
| Profit Margin | -20.90% |
| EBITDA Margin | 19.13% |
| EBIT Margin | 11.65% |
| FCF Margin | n/a |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.13% |
| Shareholder Yield | -3.13% |
| Earnings Yield | -43.99% |
| FCF Yield | -0.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Cresco Labs is 2.75, which is 136.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2.75 |
| Price Target Difference | 136.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 0.99% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.67 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.67 |
| Piotroski F-Score | 5 |